We are live on ! Find out more
INVA icon

Innoviva

149 hedge funds and large institutions have $4.11B invested in Innoviva in 2013 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 43 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 43

35% more call options, than puts

Call options by funds: $35.8M | Put options by funds: $26.6M

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

4% more funds holding

Funds holding: 143149 (+6)

4% less capital invested

Capital invested by funds: $4.28B → $4.11B (-$165M)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

Holders
149
Holders Change
+6
Holders Change %
+4.2%
% of All Funds
4.31%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.14%
New
32
Increased
63
Reduced
43
Closed
26
Calls
$35.8M
Puts
$26.6M
Net Calls
+$9.19M
Net Calls Change
-$7.6M

INVA Hedge Fund Activity: Q4 2013 in Review

149 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2013, worth a combined $4.11B — down 3.9% from $4.28B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new INVA positions and 26 closed out — a net gain of 6 holders — while 63 added to existing stakes and 43 trimmed.

The largest buyer was Baupost Group, adding an estimated $59.3M. The largest seller was BNP Paribas Financial Markets, exiting entirely with an estimated $182M sold.

  • 149 institutional investors held Innoviva (INVA) as of Q4 2013, up from 143 in Q3 2013.
  • Funds reported $4.11B of Innoviva stock for Q4 2013, down 3.9% quarter-over-quarter.
  • 32 funds opened new Innoviva positions in Q4 2013 and 26 closed out, a net change of +6 holders.
  • The largest Innoviva buyer in Q4 2013 was Baupost Group, an estimated $59.3M added.
  • The largest Innoviva seller in Q4 2013 was BNP Paribas Financial Markets, an estimated $182M sold.

Based on aggregated 13F filings for Q4 2013.